SXTP: 60 Degrees Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SXTP: 60 Degrees Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.67
Enterprise Value ($M) 12.65
Book Value ($M) 3.96
Book Value / Share 2.69
Price / Book 1.18
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -1.93
Return on Assets (ROA) -0.95
Return on Equity (ROE) -1.12

Liquidity (mrq)
Quick Ratio -0.27
Current Ratio 3.25

Balance Sheet (mrq) ($M)
Current Assets 5.39
Assets 5.76
Liabilities 1.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.68
Operating Income -9.71
Net Income -7.95

Cash Flow Statement (mra) ($M)
Cash From Operations -5.65
Cash from Investing -1.89
Cash from Financing 7.05

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 142.97
02-11 13G Intracoastal Capital, Llc 4.99
11-13 13G/A Knight Therapeutics Inc 9.10
05-07 13G/A Knight Therapeutics (Barbados) Inc. 9.97 4.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K Form 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 ☐ TRANSITION REPO
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 10,256 63,159 16.24
2025-04-16 15,143 85,623 17.69
2025-04-15 130,879 367,684 35.60
2025-04-14 70,027 328,133 21.34

(click for more detail)

Similar Companies
SPRB – Spruce Biosciences, Inc. SRZN – Surrozen, Inc.
SXTC – China SXT Pharmaceuticals, Inc. SYBX – Synlogic, Inc.
TCRT – Alaunos Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io